华夏恒生香港上市生物科技ETF(QDII)(159892)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2024/3/31 |
2,425,440,000 |
- |
2,440,380,000 |
2,435,440,000 |
100% |
2023/12/31 |
2,833,490,000 |
- |
2,858,360,000 |
2,841,630,000 |
100% |
2023/9/30 |
2,071,010,000 |
- |
2,117,760,000 |
2,097,080,000 |
99% |
2023/6/30 |
1,190,080,000 |
- |
1,253,910,000 |
1,197,250,000 |
99% |
2023/3/31 |
746,731,000 |
- |
848,477,000 |
765,694,000 |
98% |
2022/12/31 |
532,980,000 |
- |
537,797,000 |
535,833,000 |
99% |
2022/9/30 |
156,203,000 |
- |
166,920,000 |
157,574,000 |
99% |
2022/6/30 |
159,642,000 |
- |
169,828,000 |
164,686,000 |
97% |
2022/3/31 |
149,222,000 |
- |
150,859,000 |
150,679,000 |
99% |
2021/12/31 |
126,606,000 |
- |
133,806,000 |
128,444,000 |
99% |
2021/10/12 |
15,009,900 |
- |
254,310,000 |
239,139,000 |
6% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。